Atrial fibrillation is highly prevalent and often asymptomatic in patients with permanent pacemakers, yet anticoagulation for stroke prevention is markedly underutilized.
No takes yet. Share an insight, caveat, or question.
Alerts clinicians to possible anticoagulation gaps in pacemaker patients with AF; leaves open whether routine monitoring improves outcomes.
Sparks et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: